Dementia with Lewy bodies is one of the most common forms of dementia in older adults, after Alzheimer's disease. It takes its name from "Lewy bodies," abnormal clumps of a protein called alpha-synuclein, first identified by neurologist Friedrich Lewy, that accumulate inside neurons and contribute to damaging them. The disease manifests through visual hallucinations, fluctuating cognition, agitated and often violent movements during dreams, and motor symptoms similar to those of Parkinson's disease.
But contrary to what has long been assumed, the brain tissue loss it causes may not be random: it appears to preferentially affect certain regions of the brain that share specific biological characteristics.
That's what a study published in the Journal of Biomedical Science demonstrates. The research was led by an international team headed by Shady Rahayel, a professor at Université de Montréal's Faculty of Medicine and a researcher at the Center for Advanced Research in Sleep Medicine at Hôpital du Sacré-Cœur de Montréal, in collaboration with teams from McGill, Newcastle, Cambridge and Toronto, along with the Canadian Consortium on Neurodegeneration in Aging (CCNA).
Atrophy that predominates at the back of the brain
By comparing MRI brain scans of 83 people diagnosed with dementia with Lewy bodies to those of 86 healthy individuals, the researchers observed marked cortical thinning, particularly in the parietal, temporal and occipital regions, corresponding to the posterior portion of the brain, as had already been reported in previous studies.